ICD-10-CM Billable Code

M11.84

Other specified crystal arthropathies, hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Other specified crystal arthropathies of the hand, classified under ICD-10 code M11.84, are a group of joint disorders caused by the deposition of crystals in the hand joints. These conditions lead to inflammation, pain, and stiffness, impacting hand movement and quality of life. Unlike common arthritic conditions, crystal arthropathies are specifically linked to the buildup of crystal substances within the joints, precipitating inflammatory responses. Recognizing and understanding these disorders is vital for appropriate management and alleviation of symptoms.

Causes & Symptoms

Clinical Causes: Accumulation of crystal substances such as calcium pyrophosphate dihydrate (CPPD) or monosodium urate (MSU) in the hand joints Genetic predisposition that influences crystal formation Metabolic disorders like hyperparathyroidism or gout Chronic joint stress or injury Aging, which increases susceptibility to crystal deposits Dietary factors that contribute to elevated uric acid levels

Key Symptoms: Joint pain and tenderness, often sudden and severe Swelling around affected joints, especially in the fingers and wrists Stiffness, reducing the ability to move the hand freely Redness and warmth over the affected joints Repeated episodes of flare-ups that may vary in intensity Possible formation of tophi or crystal deposits under the skin around the joint

Diagnostic & Treatment

Diagnosis Path: Diagnosing other specified crystal arthropathies involves a combination of medical history evaluation, physical examination, and specialized tests. Key diagnostic steps include: - Joint aspiration: extracting synovial fluid from the affected joint to detect crystal deposits under polarized light microscopy - Imaging studies: X-rays can reveal characteristic changes such as calcification in cartilage or joint erosion - Blood tests: assessing levels of uric acid and other metabolic markers - Recognizing clinical patterns of rapid joint swelling, redness, and episodic attacks that align with crystal deposits These assessments help distinguish crystal arthropathies from other types of arthritis such as osteoarthritis or rheumatoid arthritis.

Treatment Protocols: Managing other specified crystal arthropathies aims to reduce inflammation, relieve pain, and prevent joint damage. Treatment options typically include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and reduce inflammation - Colchicine to decrease frequency of flare-ups - Corticosteroid injections directly into affected joints for rapid relief - Lifestyle modifications, including dietary changes to lower uric acid levels and manage metabolic conditions - Physical therapy to improve joint mobility and strength - In some cases, medications that influence crystal formation and metabolism might be prescribed It is essential for individuals with these conditions to work closely with healthcare providers for personalized management plans.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.84 a billable ICD-10 code?
Yes, M11.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.84?
Clinical documentation must specify the nature of Other specified crystal arthropathies, hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference